4.7 Article

Mutations in TAF8 cause a neurodegenerative disorder

Journal

BRAIN
Volume 145, Issue 9, Pages 3022-3034

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/brain/awac154

Keywords

TAF8; TFIID; neurodegenerative; psychomotor retardation

Funding

  1. German Research Foundation (DFG) [Ga354/14-1, HU 941/2-5]
  2. Niedersachsisches Ministerium fur Wissenschaft und Kultur [11-76251-12-4/12 (ZN2938)]
  3. Wellcome Trust
  4. National Institute for Health Research University College London Hospitals Biomedical Research Centre
  5. MRC [MR/S005021/1]
  6. strategic award (Synaptopathies) funding [WT093205 MA, WT104033AIA]

Ask authors/readers for more resources

Mutations in the TAF8 gene cause a severe neurodevelopmental disorder characterized by progressive brain atrophy. Similar phenotypes have been associated with mutations in other subunits of the TFIID complex. These disorders may be related to the specific vulnerability of neuronal tissue to deregulation of gene expression.
Wong et al. describe a severe neurodevelopmental disorder with progressive brain atrophy caused by variants in TAF8 coding for a subunit of the TFIID complex. Review of the literature reveals that loss of function mutations in other subunits of the TFIID complex are associated with similar phenotypes. TAF8 is part of the transcription factor II D complex, composed of the TATA-binding protein and 13 TATA-binding protein-associated factors (TAFs). Transcription factor II D is the first general transcription factor recruited at promoters to assemble the RNA polymerase II preinitiation complex. So far disorders related to variants in 5 of the 13 subunits of human transcription factor II D have been described. Recently, a child with a homozygous c.781-1G>A mutation in TAF8 has been reported. Here we describe seven further patients with mutations in TAF8 and thereby confirm the TAF8 related disorder. In two sibling patients, we identified two novel compound heterozygous TAF8 splice site mutations, c.45+4A > G and c.489G>A, which cause aberrant splicing as well as reduced expression and mislocalization of TAF8. In five further patients, the previously described c.781-1G > A mutation was present on both alleles. The clinical phenotype associated with the different TAF8 mutations is characterized by severe psychomotor retardation with almost absent development, feeding problems, microcephaly, growth retardation, spasticity and epilepsy. Cerebral imaging showed hypomyelination, a thin corpus callosum and brain atrophy. Moreover, repeated imaging in the sibling pair demonstrated progressive cerebral and cerebellar atrophy. Consistently, reduced N-acetylaspartate, a marker of neuronal viability, was observed on magnetic resonance spectroscopy. Further review of the literature shows that mutations causing a reduced expression of transcription factor II D subunits have an overlapping phenotype of microcephaly, developmental delay and intellectual disability. Although transcription factor II D plays an important role in RNA polymerase II transcription in all cells and tissues, the symptoms associated with such defects are almost exclusively neurological. This might indicate a specific vulnerability of neuronal tissue to widespread deregulation of gene expression as also seen in Rett syndrome or Cornelia de Lange syndrome.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available